{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T06:03:52Z","timestamp":1790402632055,"version":"4.1.0"},"reference-count":59,"publisher":"Cambridge University Press (CUP)","issue":"3","license":[{"start":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T00:00:00Z","timestamp":1631491200000},"content-version":"unspecified","delay-in-days":0,"URL":"https:\/\/www.cambridge.org\/core\/terms"}],"content-domain":{"domain":["cambridge.org"],"crossmark-restriction":true},"short-container-title":["Br J Nutr"],"published-print":{"date-parts":[[2022,8,14]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Adherence to the Dietary Approaches to Stop Hypertension (DASH) diet is inversely associated with type 2 diabetes mellitus (T2DM) risk. Metabolic changes due to DASH adherence and their potential relationship with incident T2DM have not been described. The objective is to determine metabolite clusters associated with adherence to a DASH-like diet in the Insulin Resistance Atherosclerosis Study cohort and explore if the clusters predicted 5-year incidence of T2DM. The current study included 570 non-diabetic multi-ethnic participants aged 40\u201369 years. Adherence to a DASH-like diet was determined a priori through an eighty-point scale for absolute intakes of the eight DASH food groups. Quantitative measurements of eighty-seven metabolites (acylcarnitines, amino acids, bile acids, sterols and fatty acids) were obtained at baseline. Metabolite clusters related to DASH adherence were determined through partial least squares (PLS) analysis using R. Multivariable-adjusted logistic regression was used to explore the associations between metabolite clusters and incident T2DM. A group of acylcarnitines and fatty acids loaded strongly on the two components retained under PLS. Among strongly loading metabolites, a select group of acylcarnitines had over 50 % of their individual variance explained by the PLS model. Component 2 was inversely associated with incident T2DM (OR: 0\u00b789; (95 % CI 0\u00b780, 0\u00b799), <jats:italic>P<\/jats:italic>-value = 0\u00b7043) after adjustment for demographic and metabolic covariates. Component 1 was not associated with T2DM risk (OR: 1\u00b702; (95 % CI 0\u00b788, 1\u00b719), <jats:italic>P<\/jats:italic>-value = 0\u00b774). Adherence to a DASH-type diet may contribute to reduced T2DM risk in part through modulations in acylcarnitine and fatty acid physiology.<\/jats:p>","DOI":"10.1017\/s0007114521003561","type":"journal-article","created":{"date-parts":[[2021,9,13]],"date-time":"2021-09-13T07:48:43Z","timestamp":1631519323000},"page":"487-497","update-policy":"https:\/\/doi.org\/10.1017\/policypage","source":"Crossref","is-referenced-by-count":8,"title":["Metabolomic profiling of the Dietary Approaches to Stop Hypertension diet provides novel insights for the nutritional epidemiology of type 2 diabetes mellitus"],"prefix":"10.1017","volume":"128","author":[{"given":"Shahen","family":"Yashpal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela D.","family":"Liese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice A.","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynne E.","family":"Wagenknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M.","family":"Haffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4169-2616","authenticated-orcid":false,"given":"Luke W.","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard P.","family":"Bazinet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Rewers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome I.","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve M.","family":"Watkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony J.","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"56","published-online":{"date-parts":[[2021,9,13]]},"reference":[{"key":"S0007114521003561_ref31","unstructured":"31. Lipomics Technologies Inc. TrueMass \u00ae Cholesterol Metabolism Panel (accessed October 2017)."},{"key":"S0007114521003561_ref23","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.108.116665"},{"key":"S0007114521003561_ref9","doi-asserted-by":"publisher","DOI":"10.3945\/jn.116.242552"},{"key":"S0007114521003561_ref55","doi-asserted-by":"publisher","DOI":"10.1080\/07315724.1999.10718830"},{"key":"S0007114521003561_ref40","doi-asserted-by":"publisher","DOI":"10.1194\/jlr.P084970"},{"key":"S0007114521003561_ref25","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.110.955922"},{"key":"S0007114521003561_ref28","doi-asserted-by":"publisher","DOI":"10.1038\/nutd.2013.32"},{"key":"S0007114521003561_ref44","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-0962"},{"key":"S0007114521003561_ref42","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.2337\/dc14-1020","article-title":"Smoking and long-term risk of type 2 diabetes: the EPIC-InterAct study in European populations","volume":"37","author":"Nilsson","year":"2014","journal-title":"Diabetes Care"},{"key":"S0007114521003561_ref2","volume-title":"Global Report on Diabetes","year":"2016"},{"key":"S0007114521003561_ref20","doi-asserted-by":"publisher","DOI":"10.1016\/S1047-2797(98)00070-2"},{"key":"S0007114521003561_ref50","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2017.272344"},{"key":"S0007114521003561_ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2012.12.021"},{"key":"S0007114521003561_ref41","doi-asserted-by":"publisher","DOI":"10.1080\/01621459.1994.10476452"},{"key":"S0007114521003561_ref1","doi-asserted-by":"publisher","DOI":"10.1007\/s12020-014-0264-4"},{"key":"S0007114521003561_ref24","doi-asserted-by":"publisher","DOI":"10.3945\/ajcn.113.063602"},{"key":"S0007114521003561_ref15","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-020-57979-8"},{"key":"S0007114521003561_ref57","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114512001602"},{"key":"S0007114521003561_ref29","unstructured":"29. US Department of Health and Human Services, National Institutes of Health & National Heart, Lung and Blood Institute (2006) Lowering Your Blood Pressure with DASH. https:\/\/www.nhlbi.nih.gov\/files\/docs\/public\/heart\/new_dash.pdf (accessed August 2018)."},{"key":"S0007114521003561_ref26","doi-asserted-by":"publisher","DOI":"10.2337\/dc09-0228"},{"key":"S0007114521003561_ref47","doi-asserted-by":"publisher","DOI":"10.1038\/nrendo.2015.129"},{"key":"S0007114521003561_ref49","doi-asserted-by":"publisher","DOI":"10.2337\/db12-0466"},{"key":"S0007114521003561_ref36","doi-asserted-by":"publisher","DOI":"10.1373\/clinchem.2010.156133"},{"key":"S0007114521003561_ref12","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.116.024261"},{"key":"S0007114521003561_ref46","doi-asserted-by":"publisher","DOI":"10.1093\/bib\/bbl016"},{"key":"S0007114521003561_ref45","unstructured":"45. Mevik, B & Wehrens, R (2016) Introduction to PLS Package in R. Date Accessed: March 2019. https:\/\/cran.r-project.org\/web\/packages\/pls\/vignettes\/pls-manual.pdf"},{"key":"S0007114521003561_ref7","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114514003341"},{"key":"S0007114521003561_ref14","doi-asserted-by":"publisher","DOI":"10.1016\/j.cardfail.2015.10.003"},{"key":"S0007114521003561_ref37","doi-asserted-by":"publisher","DOI":"10.1002\/dmrr.2514"},{"key":"S0007114521003561_ref16","doi-asserted-by":"publisher","DOI":"10.3390\/nu12051476"},{"key":"S0007114521003561_ref48","doi-asserted-by":"publisher","DOI":"10.1042\/CS20080433"},{"key":"S0007114521003561_ref5","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(94)00055-X"},{"key":"S0007114521003561_ref54","doi-asserted-by":"publisher","DOI":"10.2337\/db17-1150"},{"key":"S0007114521003561_ref10","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.2337\/db09-0580","article-title":"Metabolomics applied to diabetes research: moving from information to knowledge","volume":"58","author":"Ilkayeva","year":"2009","journal-title":"Diabetes"},{"key":"S0007114521003561_ref22","doi-asserted-by":"publisher","DOI":"10.2337\/dc15-2284"},{"key":"S0007114521003561_ref39","unstructured":"39. Mevik, B-H , Wehrens, R & Liland, KH (2018) PLS: Partial Least Squares and Principal Component Regression. https:\/\/cran.r-project.org\/web\/packages\/pls\/pls.pdf (accessed March 2019)."},{"key":"S0007114521003561_ref3","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(14)60613-9"},{"key":"S0007114521003561_ref53","doi-asserted-by":"publisher","DOI":"10.3109\/07853890.2015.1137630"},{"key":"S0007114521003561_ref52","first-page":"1695","article-title":"Increased levels of plasma acylcarnitines in obeseity and type 2 diabetes and identification of a marker of glucolipotoxicity","volume":"18","author":"Toledo","year":"2014","journal-title":"Obesity"},{"key":"S0007114521003561_ref4","doi-asserted-by":"publisher","DOI":"10.7150\/ijms.10001"},{"key":"S0007114521003561_ref19","doi-asserted-by":"publisher","DOI":"10.1113\/jphysiol.2009.184028"},{"key":"S0007114521003561_ref38","volume-title":"R: A Language and Environment for Statistical Computing","year":"2018"},{"key":"S0007114521003561_ref33","unstructured":"33. Lipomics Technologies Inc. TrueMass \u00ae Amino Acid Panel (accessed October 2017)."},{"key":"S0007114521003561_ref13","doi-asserted-by":"publisher","DOI":"10.1093\/ajcn\/nqy099"},{"key":"S0007114521003561_ref30","doi-asserted-by":"publisher","DOI":"10.3945\/jn.109.116640"},{"key":"S0007114521003561_ref35","unstructured":"35. Lipomics Technologies Inc. TrueMass \u00ae Fatty Acid Metabolism Panel (accessed October 2017)."},{"key":"S0007114521003561_ref32","unstructured":"32. Lipomics Technologies Inc. TrueMass \u00ae Bile Acid Panel (accessed October 2017)."},{"key":"S0007114521003561_ref18","first-page":"1","article-title":"Diabetes mellitus: report of a WHO study group","volume":"727","year":"1985","journal-title":"World Health Organ Tech Rep Ser"},{"key":"S0007114521003561_ref59","doi-asserted-by":"publisher","DOI":"10.1161\/HYPERTENSIONAHA.112.202705"},{"key":"S0007114521003561_ref11","doi-asserted-by":"publisher","DOI":"10.3390\/nu7064875"},{"key":"S0007114521003561_ref6","doi-asserted-by":"publisher","DOI":"10.1016\/j.nut.2012.12.018"},{"key":"S0007114521003561_ref17","doi-asserted-by":"publisher","DOI":"10.1016\/1047-2797(95)00062-3"},{"key":"S0007114521003561_ref21","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.105.559633"},{"key":"S0007114521003561_ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-013-3092-9"},{"key":"S0007114521003561_ref56","doi-asserted-by":"publisher","DOI":"10.1080\/10408398.2015.1130016"},{"key":"S0007114521003561_ref58","doi-asserted-by":"publisher","DOI":"10.33549\/physiolres.932715"},{"key":"S0007114521003561_ref34","unstructured":"34. Lipomics Technologies Inc. TrueMass \u00ae Acylcarnitine Panel (accessed October 2017)."},{"key":"S0007114521003561_ref51","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-26701-0"},{"key":"S0007114521003561_ref43","first-page":"588","article-title":"Alcohol consumption and the risk of type 2 diabetes mellitus: effect modification by hypercholesterolemia: the third Korea national health and nutrition examination survey (2005)","volume":"21","author":"Jang","year":"2012","journal-title":"Asia Pac J Clin Nutr"}],"container-title":["British Journal of Nutrition"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cambridge.org\/core\/services\/aop-cambridge-core\/content\/view\/S0007114521003561","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,15]],"date-time":"2023-05-15T02:35:51Z","timestamp":1684118151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cambridge.org\/core\/product\/identifier\/S0007114521003561\/type\/journal_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,13]]},"references-count":59,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,8,14]]}},"alternative-id":["S0007114521003561"],"URL":"https:\/\/doi.org\/10.1017\/s0007114521003561","relation":{},"ISSN":["0007-1145","1475-2662"],"issn-type":[{"value":"0007-1145","type":"print"},{"value":"1475-2662","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,13]]},"assertion":[{"value":"\u00a9 The Author(s), 2021. Published by Cambridge University Press on behalf of The Nutrition Society","name":"copyright","label":"Copyright","group":{"name":"copyright_and_licensing","label":"Copyright and Licensing"}}]}}